Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia.

Translational psychiatry - 26 Aug 2014

van Beveren N J M, Schwarz E, Noll R, Guest P C, Meijer C, de Haan L, Bahn S

Abstract excerpt

Molecular abnormalities in metabolic, hormonal and immune pathways are present in peripheral body fluids of a significant subgroup of schizophrenia patients. The authors have tested whether such disturbances also occur in psychiatrically ill and unaffected siblings of schizophrenia patients with the aim of identifying potential contributing factors to disease vulnerability. The subjects were recruited as part of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to C-Peptide
Share to Endophenotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Growth Hormone

Share to Inflammation Mediators

Share to Insulin

Share to Intracellular Signaling Peptides and Proteins

Share to Proinsulin

Share to Reference Values

Source

Open in PubMed Open full text

Identifiers

PMID: 25158005
DOI: 10.1038/tp.2014.52
PMCID: PMC4150237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia.PMID 25158005Read ↗

Associations between SNPs and immune-related circulating proteins in schizophrenia.Semantic proximity Read ↗

The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study.Semantic proximity Read ↗

Metabolome in schizophrenia and other psychotic disorders: a general population-based studySemantic proximity Read ↗

Distinct Molecular Phenotypes in Male and Female Schizophrenia PatientsSemantic proximity Read ↗

Central and peripheral molecular profiling of sex differences in schizophrenia, major depressive disorder, and controlsSemantic proximity Read ↗

Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic TreatmentSemantic proximity Read ↗

No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample.Semantic proximity Read ↗

Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activationSemantic proximity Read ↗

Polygenic risk for schizophrenia and bipolar disorder in relation to cardiovascular biomarkersSemantic proximity Read ↗

The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.Semantic proximity Read ↗

Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia.Semantic proximity Read ↗

Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.